Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk: Insights from Proteomic and Metabolomic Mediators JACC: CardioOncology

Author Interview: Social Drivers of Health Advisory: Cardiovascular Disease Projections Through 2050 JACC: Advances

Aug 25, 2026 - 24:02

Dinesh Kalra and Khadijah Breathett discuss the estimated future projections of risk factors for CVD, ind...View more

Computed Tomography–Derived Abrupt Wall-Thickness Transitions as Complementary Markers of Ventricular Tachycardia Substrate in Ischemic Cardiomyopathy

Aug 20, 2026 - 05:12

In this episode, Frank Marchlinski, MD, Deputy Editor of JACC: Clinical Electrophysiology, discusses a st...View more

Author Interview: INSIGHT Model: Explainable Artificial Intelligence for Real-World EHR-Based Screening of Transthyretin Amyloidosis Cardiomyopathy JACC: Advances

Aug 20, 2026 - 16:42

Dinesh Kalra and Javed Butler discuss the development of an artificial intelligence screening tool to ide...View more

Feasibility and Safety of Strategic Multielectrode Positioning Guided by S3 Protocol for Hemodynamically Unstable Ventricular Tachycardia: The S3-STaMP Project JACC: Clinical Electrophysiology

Aug 19, 2026 - 04:43

Francis E. Marchlinski, MD, Deputy Editor of JACC: Clinical Electrophysiology, discusses the S3-STaMP stu...View more

August 2026 Issue Summary JACC: CardioOncology

Aug 18, 2026 - 17:14

Dr. Ky's August 2026 Issue Summary.

Divergent effects of GnRH agonist and GnRH antagonist treatment on platelet activity and transcriptome JACC: CardioOncology

Aug 18, 2026 - 04:43

Commentary by Dr. Deng Ye on behalf of Leilei Cheng.

Hemoglobin Decline After Oral Anticoagulation Initiation and Subsequent Cancer Detection in Patients with Atrial Fibrillation JACC: CardioOncology

Aug 18, 2026 - 04:14

A Simple Clinical Risk Score to Improve Prediction of Anthracycline-Induced Cardiotoxicity JACC: CardioOncology

Aug 18, 2026 - 03:42